(Q43886809)

27 November 2017

title

Evaluation of protective effect of multiantigenic DNA vaccine encoding MIC3 and ROP18 antigen segments of Toxoplasma gondii in mice (English)

1 reference

27 November 2017

0 references

Daofeng Qu

1

1 reference

27 November 2017

Jianzhong Han

series ordinal

2

1 reference

27 November 2017

Aifang Du

series ordinal

3

1 reference

27 November 2017

language of work or name

1 reference

17 April 2013

1 reference

27 November 2017

published in

Parasitology Research

1 reference

27 November 2017

volume

112

1 reference

27 November 2017

issue

7

1 reference

27 November 2017

page(s)

2593-2599

1 reference

DNA vaccines: are they still just a powerful tool for the future?

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Toxoplasma gondii infections in chickens (Gallus domesticus): prevalence, clinical disease, diagnosis and public health significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

ROP18 is a rhoptry kinase controlling the intracellular proliferation of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Evaluation of immune responses induced by SAG1 and MIC3 vaccine cocktails against Toxoplasma gondii.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Toxoplasma gondii microneme protein 8 (MIC8) is a potential vaccine candidate against toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Induction of protective immunity by multiantigenic DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Induction of protective immune responses by a multiantigenic DNA vaccine encoding GRA7 and ROP1 of Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Seroprevalence of Toxoplasma gondii infection among immigrant and native pregnant women in Eastern Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Polymorphic secreted kinases are key virulence factors in toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

B cells are essential for vaccination-induced resistance to virulent Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Toxoplasma gondii: protective effect of an intranasal SAG1 and MIC4 DNA vaccine in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Multicomponent DNA vaccine-encoding Toxoplasma gondii GRA1 and SAG1 primes: anti-Toxoplasma immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

IL-4-mediated inhibition of IFN-gamma production by CD4+ T cells proceeds by several developmentally regulated mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing TgAMA1 as vaccines against Toxoplasma gondii infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-013-3425-0

Induction of protective Th1 immune responses in mice by vaccination with recombinant Toxoplasma gondii nucleoside triphosphate hydrolase-II

21 January 2018

1 reference

12 December 2020

The immune responses of sheep after DNA immunization with, Toxoplasma gondii MAG1 antigen-with and without co-expression of ovine interleukin 6

1 reference

12 December 2020

Evaluation of the immune response induced by multiantigenic DNA vaccine encoding SAG1 and ROP2 of Toxoplasma gondii and the adjuvant properties of murine interleukin-12 plasmid in BALB/c mice

1 reference

12 December 2020

Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice

1 reference

12 December 2020

Ginsenoside Rg1 enhances immune response induced by recombinant Toxoplasma gondii SAG1 antigen

1 reference

12 December 2020

Different roles for interleukin-4 during the course of Toxoplasma gondii infection

1 reference

12 December 2020

Protective immune response in BALB/c mice induced by a suicidal DNA vaccine of the MIC3 gene of Toxoplasma gondii

1 reference

12 December 2020

Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris

1 reference

12 December 2020

10.1007/S00436-013-3425-0

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

1022806650

0 references

1 reference